{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:14:47Z","timestamp":1790882087798,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,11,12]],"date-time":"2013-11-12T00:00:00Z","timestamp":1384214400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s10875-013-9964-4","type":"journal-article","created":{"date-parts":[[2013,11,11]],"date-time":"2013-11-11T08:31:25Z","timestamp":1384158685000},"page":"53-57","source":"Crossref","is-referenced-by-count":9,"title":["Allogeneic Bone Marrow Transplantation Appears to Ameliorate IgA Nephropathy in a Patient with X-linked Thrombocytopenia"],"prefix":"10.1007","volume":"34","author":[{"given":"Akihiro","family":"Hoshino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyoshi","family":"Matsukura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisano","family":"Sakaki-Nakatsubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Miyawaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Kanegane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,11,12]]},"reference":[{"key":"9964_CR1","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jaci.2006.02.005","volume":"117","author":"HD Ochs","year":"2006","unstructured":"Ochs HD, Thrasher AJ. The Wiskott-Aldrich syndrome. J Allergy Clin Immunol. 2006;117:725\u201338.","journal-title":"J Allergy Clin Immunol"},{"key":"9964_CR2","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/ng0495-414","volume":"9","author":"A Villa","year":"1995","unstructured":"Villa A, Notarangelo L, Macchi P, Mantuano E, Cavagni G, Brugnoni D, et al. X-linked thrombocytopenia and Wiskott-Aldrich syndrome are allelic diseases with mutations in the WASP gene. Nat Genet. 1995;9:414\u20137.","journal-title":"Nat Genet"},{"key":"9964_CR3","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1182\/blood-2003-05-1480","volume":"103","author":"K Imai","year":"2004","unstructured":"Imai K, Morio T, Zhu Y, Jin Y, Itoh S, Kajiwara M, et al. Clinicalcourse of patients with WASP gene mutations. Blood. 2004;103:456\u201364.","journal-title":"Blood"},{"key":"9964_CR4","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1182\/blood-2009-09-239087","volume":"115","author":"MH Albert","year":"2010","unstructured":"Albert MH, Bittner TC, Nonoyama S, Notarangelo LD, Burns S, Imai K, et al. X-linked thrombocytopenia (XLT) due to WAS mutations: clinical characteristics, long-term outcome, and treatment options. Blood. 2010;115:3231\u20138.","journal-title":"Blood"},{"key":"9964_CR5","doi-asserted-by":"crossref","first-page":"e622","DOI":"10.1542\/peds.111.5.e622","volume":"111","author":"S Dupuis-Girod","year":"2003","unstructured":"Dupuis-Girod S, Medioni J, Haddad E, Quartier P, Cavazzana-Calvo M, Le Deist F, et al. Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients. Pediatrics. 2003;111:e622\u20137.","journal-title":"Pediatrics"},{"key":"9964_CR6","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/ki.2011.501","volume":"81","author":"JK Boyd","year":"2012","unstructured":"Boyd JK, Cheung CK, Molyneux K, Feehally J, Barratt J. An update on the pathogenesis and treatment of IgA nephropathy. Kidney Int. 2012;81:833\u201343.","journal-title":"Kidney Int"},{"key":"9964_CR7","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1442-200X.2011.03469.x","volume":"53","author":"Y Kawasaki","year":"2011","unstructured":"Kawasaki Y. Mechanism of onset and exacerbation of chronic glomerulonephritis and its treatment. Pediatr Int. 2011;53:795\u2013806.","journal-title":"Pediatr Int"},{"key":"9964_CR8","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/sj.ki.5002185","volume":"71","author":"Z Moldoveanu","year":"2007","unstructured":"Moldoveanu Z, Wyatt RJ, Lee JY, Tomana M, Julian BA, Mestecky J, et al. Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int. 2007;71:1148\u201354.","journal-title":"Kidney Int"},{"key":"9964_CR9","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.clim.2011.10.001","volume":"142","author":"M Shimizu","year":"2012","unstructured":"Shimizu M, Nikolov NP, Ueno K, Ohta K, Siegel RM, Yachie A, et al. Development of IgA nephropathy-like glomerulonephritis associated with Wiskott-Aldrich syndrome protein deficiency. Clin Immunol. 2012;142:160\u20136.","journal-title":"Clin Immunol"},{"key":"9964_CR10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1172\/JCI29539","volume":"117","author":"S Humblet-Baron","year":"2007","unstructured":"Humblet-Baron S, Sather B, Anover S, Becker-Herman S, Kasprowicz DJ, Khim S, et al. Wiskott-Aldrich syndrome protein is required for regulatory T cell homeostasis. J Clin Invest. 2007;117:407\u201318.","journal-title":"J Clin Invest"},{"key":"9964_CR11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1084\/jem.20061338","volume":"204","author":"MH Maillard","year":"2007","unstructured":"Maillard MH, Cotta-de-Almeida V, Takeshima F, Nguyen DD, Michetti P, Nagler C, et al. The Wiskott-Aldrich syndrome protein is required for the function of CD4+CD25+Foxp3+ regulatory T cells. J Exp Med. 2007;204:381\u201391.","journal-title":"J Exp Med"},{"key":"9964_CR12","doi-asserted-by":"crossref","first-page":"7451","DOI":"10.4049\/jimmunol.177.10.7451","volume":"177","author":"S Trifari","year":"2006","unstructured":"Trifari S, Sitia G, Aiuti A, Scaramuzza S, Marangoni F, Guidotti LG, et al. Defective Th1 cytokine gene transcription in CD4+ and CD8+ T cells from Wiskott-Aldrich syndrome patients. J Immunol. 2006;177:7451\u201361.","journal-title":"J Immunol"},{"key":"9964_CR13","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1053\/j.ajkd.2003.11.016","volume":"43","author":"H Matsukura","year":"2004","unstructured":"Matsukura H, Kanegane H, Miya K, Ohtsubo K, Higuchi A, Tanizawa T, et al. IgA nephropathy associated with X-linked thrombocytopenia. Am J Kidney Dis. 2004;43:e7\u201312.","journal-title":"Am J Kidney Dis"},{"key":"9964_CR14","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jaci.2012.08.040","volume":"131","author":"M Shimizu","year":"2013","unstructured":"Shimizu M, Kanegane H, Wada T, Motoyoshi Y, Morio T, Candotti F, et al. Aberrant glycosylation of IgA in Wiskott-Aldrich syndrome and X-linked thrombocytopenia. J Allergy Clin Immunol. 2013;131:587\u201390.","journal-title":"J Allergy Clin Immunol"},{"key":"9964_CR15","unstructured":"Sakai O. IgA nephropathy: current concepts and future trends. Nephrology 1997;3: 2\u20133."},{"key":"9964_CR16","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1046\/j.1523-1755.1999.00750.x","volume":"56","author":"T Imasawa","year":"1999","unstructured":"Imasawa T, Nagasawa R, Utsunomiya Y, Kawamura T, Zhong Y, Makita N, et al. Bone marrow transplantation attenuates murine IgA nephropathy: role of a stem cell disorder. Kidney Int. 1999;56:1809\u201317.","journal-title":"Kidney Int"},{"key":"9964_CR17","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.ki.5002300","volume":"72","author":"H Suzuki","year":"2007","unstructured":"Suzuki H, Suzuki Y, Aizawa M, Yamanaka T, Kihara M, Pang H, et al. Th1 polarization in murine IgA nephropathy directed by bone marrow-derived cells. Kidney Int. 2007;72:319\u201327.","journal-title":"Kidney Int"},{"key":"9964_CR18","first-page":"120","volume":"157","author":"T Inoue","year":"2007","unstructured":"Inoue T, Sugiyama H, Kikumoto Y, Fukuoka N, Maeshima Y, Hattori H, et al. Downregulation of the beta1, 3- galactosyl transferasegene in tonsillar B lymphocytes and aberrant lectin bindings to tonsillar IgA as a pathogenesis of IgA nephropathy. Contrib Nephrol. 2007;157:120\u20134.","journal-title":"Contrib Nephrol"},{"key":"9964_CR19","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1093\/ndt\/gfq325","volume":"25","author":"K Yamada","year":"2010","unstructured":"Yamada K, Kobayashi N, Ikeda T, Suzuki Y, Tsuge T, Horikoshi S, et al. Down-regulation of core 1 beta1, 3-galactosyl transferase and Cosmc by Th2 cytokine alters O-glycosylation of IgA1. Nephrol Dial Transplant. 2010;25:3890\u20137.","journal-title":"Nephrol Dial Transplant"},{"key":"9964_CR20","first-page":"629","volume":"118","author":"H Suzuki","year":"2008","unstructured":"Suzuki H, Moldoveanu Z, Hall S, Brown R, Vu HL, Novak L, et al. IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. J Clin Invest. 2008;118:629\u201339.","journal-title":"J Clin Invest"},{"key":"9964_CR21","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1681\/ASN.2007121311","volume":"19","author":"H Suzuki","year":"2008","unstructured":"Suzuki H, Suzuki Y, Narita I, Aizawa M, Kihara M, Yamanaka T, et al. Toll-like receptor 9 affects severity of IgA nephropathy. J Am Soc Nephrol. 2008;19:2384\u201395.","journal-title":"J Am Soc Nephrol"},{"key":"9964_CR22","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00431-010-1325-1","volume":"170","author":"HJ Park","year":"2011","unstructured":"Park HJ, Hahn WH, Suh JS, Kim MJ, Kang SW, Lee JS, et al. Association between toll-like receptor 10 (TLR10) gene polymorphisms and childhood IgA nephropathy. Eur J Pediatr. 2011;170:503\u20139.","journal-title":"Eur J Pediatr"},{"key":"9964_CR23","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1093\/ndt\/17.12.2108","volume":"17","author":"I Kobayashi","year":"2002","unstructured":"Kobayashi I, Nogaki F, Kusano H, Ono T, Miyawaki S, Yoshida H, et al. Interleukin-12 alters the physicochemical characteristics of serum and glomerular IgA and modifies glycosylation in a ddY mouse strain having high IgA levels. Nephrol Dial Transplant. 2002;17:2108\u201316.","journal-title":"Nephrol Dial Transplant"},{"key":"9964_CR24","first-page":"2208","volume":"19","author":"X Cuevas","year":"1987","unstructured":"Cuevas X, Lloveras J, Mir M, Aubia J, Masramon J. Disappearance of mesangial IgA deposits from the kidneys of two donors after transplantation. Transplant Proc. 1987;19:2208\u20139.","journal-title":"Transplant Proc"},{"key":"9964_CR25","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1016\/S0041-1345(97)00957-3","volume":"29","author":"M Koselj","year":"1997","unstructured":"Koselj M, Rott T, Kandus A, Vizjak A, Malovrh M. Donor-transmitted IgA nephropathy: long-term follow-up of kidney donors and recipients. Transplant Proc. 1997;29:3406\u20137.","journal-title":"Transplant Proc"},{"key":"9964_CR26","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1182\/blood-2007-03-076679","volume":"111","author":"H Ozsahin","year":"2008","unstructured":"Ozsahin H, Cavazzana-Calvo M, Notarangelo LD, Schulz A, Thrasher AJ, Mazzolari E, et al. Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation. Blood. 2008;111:439\u201345.","journal-title":"Blood"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-013-9964-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-013-9964-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-013-9964-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T04:14:56Z","timestamp":1559276096000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-013-9964-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,12]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["9964"],"URL":"https:\/\/doi.org\/10.1007\/s10875-013-9964-4","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,12]]}}}